From Avoidance to Acceptance: How to Diagnose, Document, and Treat Needle Phobia in Clinical Practice

A 35-year-old man sits in your office. He has avoided medical care for over a decade. His last physical was when he was 22. His blood pressure is consistently elevated in any clinical setting, but he refuses to have it checked again. He knows he needs routine blood work, vaccinations, and possibly a dental procedure. His primary care physician has all but given up on convincing him.

He is not difficult, oppositional, or medically noncompliant by choice. He is terrified. His heart races at the mere mention of a needle. He would rather risk a serious, preventable illness than sit through a 60‑second blood draw.

This is not a personality flaw. It is a specific phobia — one that is surprisingly common, profoundly disabling, and remarkably treatable.

Needle phobia, clinically coded as F40.231 (Fear of injections and transfusions) , affects approximately 3.5 to 10 percent of the general population. Among children, the prevalence is significantly higher, reaching 20‑50 percent in some studies. Yet despite its frequency, needle phobia is often dismissed as minor, minimized by medical professionals, or hidden by patients who feel ashamed of their fear. The result is millions of people avoiding necessary medical care — skipping vaccinations, delaying cancer screenings, avoiding blood tests for chronic conditions — with serious consequences for public health.

This article provides a comprehensive clinical overview of needle phobia: its diagnostic criteria, its subtypes, its neurobiological basis, its functional consequences, and its evidence‑based treatments. For the psychotherapist, understanding F40.231 is not merely an exercise in diagnostic coding — it is the first step in treating a condition that can literally save lives by enabling patients to access the medical care they desperately need but cannot tolerate.

The Code — What F40.231 Actually Means

The ICD‑10‑CM code F40.231 is the specific, billable diagnosis code for "Fear of injections and transfusions" , commonly referred to as needle phobia. It falls within the broader category F40.23 (Blood, injection, injury type phobia) under the mental disorder classification for specific phobias (F40.2).

The code structure is hierarchical:

• F40 : Phobic anxiety disorders

• F40.2 : Specific (isolated) phobias

• F40.23 : Blood, injection, injury type phobia

• F40.231 : Fear of injections and transfusions (needle phobia)

Related codes in the same family:

• F40.230 : Fear of blood (hemophobia)

• F40.232 : Fear of other medical care

• F40.233 : Fear of injury

These related phobias share common features — vasovagal responses, avoidance of medical settings — but differ in the specific trigger. Needle phobia is distinct from fear of blood, though the two commonly co‑occur. A patient with F40.231 may have no difficulty seeing blood, provided no needle is involved. Conversely, a patient with F40.230 (fear of blood) may panic at the sight of a blood draw but be unbothered by an injection.

Why specificity matters: Accurate coding of F40.231 rather than a general anxiety diagnosis (F41.9) or an unspecified phobia (F40.9) justifies treatment for a condition with specific evidence‑based interventions (exposure therapy, cognitive restructuring, applied tension technique). It also communicates to other providers precisely what the patient fears, enabling appropriate accommodations during medical procedures.

According to ICD‑10‑CM guidelines, F40.231 is a billable/specific code , meaning it can be used for reimbursement purposes when the diagnostic criteria are met and properly documented. The code requires, per clinical definition, that the fear be centered on needles, cause significant distress, and result in avoidance behavior that interferes with the patient's ability to receive necessary medical care.

The Diagnostic Criteria — When Does Fear Become Phobia?

Not every unpleasant feeling about needles qualifies as a phobia. The transition from normative fear to clinical phobia is defined by the intensity of the response, the degree of avoidance, and the resulting functional impairment.

According to ICD‑10 and DSM‑5 criteria, a diagnosis of specific phobia (including F40.231) requires:

1. Marked fear or anxiety about a specific object or situation (needles/injections). In children, this may be expressed by crying, tantrums, freezing, or clinging behavior.

2. The phobic object or situation almost always provokes immediate fear or anxiety. This response is not merely "dislike" or "discomfort" — it is a physiologically intense reaction, often including palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, and, distinctively for blood‑injection‑injury phobia, a vasovagal response (fainting).

3. The phobic object or situation is actively avoided or endured with intense fear or anxiety. A patient with needle phobia will not simply "gut it out" without significant distress. They may cancel appointments, refuse recommended procedures, or require extensive accommodation (e.g., lying down, numbing cream, benzodiazepines) to tolerate the procedure.

4. The fear or anxiety is out of proportion to the actual danger posed by the specific object or situation. Modern medical needles are small, sterile, and associated with minimal objective risk. The patient's response — including potentially fainting — far exceeds the actual threat.

5. The fear, anxiety, or avoidance is persistent, typically lasting for six months or more. Transient fear following a traumatic injection (e.g., a painful childhood vaccination) may resolve on its own without meeting the duration threshold for phobia.

6. The fear, anxiety, or avoidance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. This is the critical functional criterion. For needle phobia, the impairment is most often in the healthcare domain : avoiding necessary medical care, delaying diagnosis and treatment, nonadherence to prescribed medications requiring blood monitoring, and refusal of vaccinations.

The vasovagal distinction: Needle phobia is unique among specific phobias in its physiological response pattern. Unlike most phobias — which produce a sympathetic surge (increased heart rate, blood pressure, and arousal) — a significant subset of patients with blood‑injection‑injury phobia experience a vasovagal response: an initial sympathetic surge followed by a sudden drop in heart rate and blood pressure, leading to dizziness, pallor, nausea, and fainting.

This biphasic response has important treatment implications: exposure therapy for needle phobia must be modified to prevent fainting, and patients may benefit from the applied tension technique to maintain blood pressure during exposure.

Differential diagnosis: Before assigning F40.231, rule out other conditions that may present with avoidance of needles:

• Generalized anxiety disorder (F41.1): Worry about needles would be one of many worries, not the specific, circumscribed trigger.

• Post‑traumatic stress disorder (F43.10): Fear of needles may be a conditioned response following a traumatic medical event (e.g., childhood hospitalization, sexual assault involving needles). In such cases, the diagnosis may be PTSD rather than specific phobia.

• Somatic symptom disorder (F45.1): Physical symptoms during needle exposure may be misinterpreted as evidence of serious illness, not simply feared.

• Avoidant/restrictive food intake disorder (F50.8): Not applicable.

• Psychotic disorders (F20‑F29): Avoidance is not based on delusional beliefs about needles.

The thorough diagnostic assessment should include a clinical interview, the use of validated specific phobia scales, and collateral information from medical providers who have attempted procedures.

The Epidemiology — How Common Is Needle Phobia?

Needle phobia is far more common than most clinicians realize. Prevalence estimates vary by population and methodology, but the data consistently show a significant burden:

• General adult population: 3.5‑10 percent meet criteria for blood‑injection‑injury phobia. Because needle phobia is a subtype of this broader category, the prevalence specifically for fear of injections is at the lower end of this range but remains substantial.

• Children and adolescents: Prevalence among pediatric populations is significantly higher, ranging from 20‑50 percent depending on age and methodology. Needle fears typically emerge between ages 4 and 6 and may decline with age, though a significant subset persists into adulthood.

• Chronic disease populations: Among individuals requiring regular injections or blood draws — patients with diabetes, autoimmune disorders, bleeding disorders, or those on long‑term anticoagulation — the prevalence of needle phobia is elevated. Studies suggest that 15‑30 percent of adults with diabetes report clinically significant fear of self‑injection or blood glucose testing, which contributes to poor glycemic control.

• Vaccination refusal: Needle phobia is a significant contributor to vaccine hesitancy among adults. Research indicates that approximately 10‑15 percent of adults who decline influenza vaccination cite fear of needles as either the primary or contributing reason.

Patients with needle phobia are not a small, niche population. They are a substantial minority of the general public, and they are disproportionately likely to be found in the offices of primary care physicians, not mental health specialists — because they avoid mental health care as well.

The Etiology — Where Does Needle Phobia Come From?

The development of needle phobia is multifactorial, involving genetic predisposition, learning history, and physiological response patterns.

4.1 Genetic and Familial Factors

Blood‑injection‑injury phobia has a heritable component. Twin studies suggest that approximately 30‑40 percent of the variance in risk is attributable to genetic factors. The vasovagal response tendency is partially heritable, and families with a history of fainting during medical procedures are overrepresented among individuals with needle phobia.

4.2 Direct Conditioning (Classical Conditioning)

The most common pathway to needle phobia is direct negative experience: a painful injection, a difficult blood draw, or a traumatic medical procedure early in life. The unconditioned stimulus (pain) becomes associated with the conditioned stimulus (needle) through classical conditioning, producing a conditioned fear response. This is especially potent when the experience occurs in childhood, when the brain's fear circuits are highly plastic.

One study found that among adults with needle phobia, over 60 percent recalled a specific painful or frightening needle experience in childhood — most commonly a dental injection, vaccination, or blood draw.

4.3 Vicarious Conditioning (Observational Learning)

Needle phobia can also develop through observational learning: watching a parent, sibling, or peer respond with intense fear or fainting during a needle procedure. Children are particularly susceptible to this pathway; a parent who visibly panics during their own blood draw may inadvertently teach their child that needles are dangerous.

4.4 Informational Transmission

Verbal instruction — "needles are scary," "don't look," "this will hurt" — can also contribute to fear acquisition, particularly when the information comes from a trusted source (parent, physician, nurse) and is emotionally charged.

4.5 The Vasovagal Component

The unique physiological response pattern in blood‑injection‑injury phobia — the biphasic sympathetic‑then‑parasympathetic response leading to fainting — may have an evolutionary basis. The sudden drop in blood pressure during a bleeding injury would be adaptive in a primitive context, reducing blood loss. In modern medical settings, the same response is triggered by the anticipation of a needle — a harmless stimulus — producing maladaptive fainting.

The vasovagal response is not a learned fear in the traditional sense. It may be better understood as a reflex that has been pathologically conditioned to a harmless cue. This has important treatment implications: cognitive restructuring alone may be insufficient; physiological interventions (applied tension technique) are often necessary.

4.6 Developmental Trajectory

Needle fears typically emerge in early to middle childhood (ages 4‑10), peak in prevalence during elementary school years, and then follow one of three trajectories:

• Remission: Fear resolves spontaneously or through gradual exposure (routine medical care, vaccinations).

• Persistence with accommodation: Fear remains but is managed; patient tolerates necessary procedures with coping strategies (distraction, numbing cream, support person).

• Chronic, impairing phobia: Fear generalizes, avoidance intensifies, and patient avoids necessary medical care entirely, leading to serious health consequences.

Identifying which trajectory a patient is on requires assessment of symptom severity, avoidance behavior, and functional impairment.

The Functional Consequences — How Needle Phobia Harms Health

Needle phobia is not merely unpleasant. It has documented, serious health consequences.

Avoidance of Preventive Care

Individuals with needle phobia are significantly less likely to receive routine vaccinations, including influenza, tetanus, hepatitis B, and HPV vaccines. During the COVID‑19 pandemic, needle phobia was identified as a significant barrier to vaccination uptake, with studies estimating that 5‑10 percent of unvaccinated adults cited fear of needles as a primary reason.

Delayed Diagnosis

Patients with needle phobia avoid blood draws, delaying diagnosis of conditions such as diabetes, thyroid disorders, anemia, infectious diseases, and malignancies. A patient may present with symptoms for years before finally agreeing to diagnostic blood work — by which time the condition may have progressed to a less treatable stage.

Poor Disease Management

For patients with chronic conditions requiring regular blood monitoring (e.g., diabetes, hyperlipidemia, anticoagulant therapy), needle phobia can lead to treatment nonadherence. A patient with diabetes who cannot tolerate finger sticks or insulin injections will have poor glycemic control, increasing the risk of neuropathy, retinopathy, and cardiovascular disease.

Avoidance of Other Needle‑Based Procedures

Needle phobia extends beyond injections and blood draws to include dental procedures (local anesthetic injections), acupuncture, tattooing, and body piercing. Patients may avoid necessary dental care, leading to preventable oral health deterioration.

Psychiatric Comorbidity

Needle phobia does not exist in isolation. It is associated with elevated rates of generalized anxiety disorder, panic disorder, agoraphobia (avoidance of medical settings), and major depression (secondary to health deterioration and avoidance). The phobia may also co‑occur with other specific phobias, particularly hemophobia (fear of blood) and iatrophobia (fear of doctors).

Economic Burden

The healthcare costs associated with needle phobia are substantial: additional visits to accommodate anxious patients, sedation or anxiolytic medication before procedures, emergency department visits for untreated conditions, and hospitalizations for preventable diseases.

One study estimated that the average patient with needle phobia incurs 25‑50 percent higher healthcare costs than matched controls, due to a combination of avoidance leading to acute exacerbations, and the extra resources required to manage the phobic patient when care is finally obtained.

Evidence‑Based Treatment — What Works for F40.231

Needle phobia is highly treatable. The evidence base supports several effective interventions.

6.1 Cognitive‑Behavioral Therapy (CBT)

CBT is the first‑line psychological treatment for specific phobias, including F40.231. Core components include:

• Psychoeducation: Explaining the nature of phobia, the vasovagal response, and the rationale for exposure.

• Cognitive restructuring: Challenging catastrophic beliefs about needles ("I will die," "I will pass out and hit my head," "The needle will break off in my arm").

• Exposure therapy: Gradual, systematic exposure to phobic stimuli, typically in a hierarchy from least to most anxiety‑provoking.

Exposure for needle phobia should include:

• Looking at pictures of needles

• Holding a capped needle (syringe)

• Watching videos of injections

• Touching the skin with the capped needle

• Simulated (dry) needle insertion

• Actual needle insertion with a patient who has consented

Modification for vasovagal response: Standard exposure therapy may need to be modified for patients with the vasovagal subtype, who may faint during intense exposure. The applied tension technique (see below) should be taught before in‑vivo exposure to prevent fainting.

6.2 Applied Tension Technique (ATT)

The applied tension technique is a specific, evidence‑based intervention designed for blood‑injection‑injury phobia with vasovagal response. It is not necessary for patients without the vasovagal subtype.

Procedure:

1. The patient sits or lies down and tenses the muscles of the arms, legs, and torso for 10‑15 seconds.

2. The patient then releases the tension and notices the rush of blood back to the head.

3. The sequence is repeated 5‑6 times.

4. The patient practices ATT daily and immediately before any feared injection or blood draw.

Mechanism: ATT raises blood pressure through muscle tension, preventing the vasovagal fainting response. One study found that ATT reduced fainting rates from 80 percent to 30‑40 percent in patients with blood‑injection‑injury phobia.

6.3 Applied Relaxation

For patients without vasovagal response — those whose response is purely sympathetic (tachycardia, hypertension, panic) — applied relaxation may be beneficial. The patient learns to rapidly relax muscles and slow breathing in response to phobic stimuli.

6.4 In Vivo Exposure in Medical Settings

The most effective exposure for needle phobia is actual exposure to needles in a controlled, supportive medical setting. This requires collaboration with a physician, nurse, or phlebotomist. The patient may start with a dry needle (no actual puncture) and gradually work up to a full blood draw or injection.

During the procedure, the patient practices ATT or applied relaxation. The therapist or support person provides coaching and reassurance.

6.5 Pharmacological Interventions

For patients with severe needle phobia who cannot tolerate even imaginal exposure, pharmacological interventions may be used as an adjunct:

• Benzodiazepines (e.g., lorazepam, alprazolam) before the procedure can reduce anticipatory anxiety, though they do not treat the underlying phobia and carry risks of dependence and sedation.

• Topical anesthetics (lidocaine cream, ethyl chloride spray) can reduce the pain of needle insertion, removing one unconditioned stimulus that maintains the fear.

• Nitrous oxide (laughing gas) can be used for particularly anxious patients during dental procedures.

Pharmacological interventions should be combined with psychological treatment, not used as a standalone approach.

6.6 Virtual Reality Exposure

Emerging evidence supports the use of virtual reality (VR) exposure therapy for needle phobia. VR allows patients to experience increasingly threatening needle scenarios in a controlled, immersive environment without actual risk. VR exposure may be particularly useful for patients who cannot tolerate in‑vivo exposure initially.

6.7 One‑Session Treatment (OST)

For motivated patients, intensive one‑session treatment (3‑4 hours) has been shown to be effective for specific phobias, including needle phobia. OST combines psychoeducation, cognitive restructuring, and prolonged in‑vivo exposure in a single extended session. Gains are typically maintained at follow‑up.

Part 7: Documentation for F40.231 — What Auditors Look For

To justify the diagnosis of F40.231 and the medical necessity of treatment, clinical documentation must include specific elements.

Essential elements for a defensible note:

1. Specific phobic stimulus identified: "Fear of injections and transfusions (needles)" — not merely "anxiety about medical procedures."

2. Criterion A (marked fear or anxiety): Describe the intensity of the fear response. "Patient reports heart rate increases to 120, feels dizzy, and fears fainting at the mere sight of an uncapped needle."

3. Criterion B (immediate fear upon exposure): "Phobic response occurs within seconds of needle presentation."

4. Criterion C (avoidance): "Patient has declined influenza vaccination for 5 consecutive years. Has not had blood work in 8 years despite physician recommendation."

5. Criterion D (out of proportion): "Patient acknowledges that the actual danger of a needle is minimal but cannot control the fear response."

6. Criterion E (duration): "Symptoms have been present since childhood, over 12 years."

7. Criterion F (functional impairment): Document specific health consequences. "Due to avoidance of blood draws, patient has not been screened for diabetes or hyperlipidemia. Avoids dental care, leading to untreated periodontal disease."

8. Vasovagal subtype (if present): "Patient reports history of fainting during previous blood draws."

9. Rule‑out of other conditions: "Symptoms are not better accounted for by PTSD (no trauma history), generalized anxiety (worry not generalized), or psychotic disorder (no delusional beliefs)."

Sample diagnostic note:

"Patient, age 34, presents with lifelong fear of needles (F40.231). She reports that any exposure to injections or blood draws produces immediate panic symptoms including palpitations, shortness of breath, and dizziness, with one prior episode of syncope (fainting) during a blood draw 3 years ago. She has declined all recommended vaccinations for the past 6 years and has not had routine blood work in 5 years despite physician recommendations. She acknowledges that needles pose minimal objective risk but reports that her fear is 'completely uncontrollable.' Onset was in childhood following a painful dental injection. Duration exceeds 6 months. Rule‑out of other anxiety disorders, PTSD, and medical conditions has been completed. Patient meets full DSM‑5 criteria for specific phobia (blood‑injection‑injury type). Treatment plan: Psychoeducation, applied tension technique (ATT), and graduated exposure therapy with collaboration from primary care for in‑vivo exposure."

Part 8: Special Populations — Children, Diabetes, Cancer

Needle phobia presents differently in special populations, requiring tailored assessment and intervention.

8.1 Children

Prevalence is highest in childhood, but untreated needle phobia in children carries the risk of persisting into adulthood. Pediatric interventions should:

• Include parents in treatment; parental anxiety is a risk factor for child phobia.

• Use developmentally appropriate language and metaphors.

• Incorporate play‑based exposure (toy medical kits, "giving shots" to stuffed animals).

• Consider topical anesthetics before any needle procedure to reduce pain.

8.2 Patients with Diabetes

Needle phobia in diabetes (type 1 or type 2) is associated with poor glycemic control, increased complications, and reduced quality of life. Interventions should:

• Address both fear of self‑injection and fear of finger sticks.

• Use injection aids (needle guides, auto‑injectors).

• Teach ATT for those with vasovagal response.

• Consider continuous glucose monitors and insulin pumps (which reduce but do not eliminate needle exposure).

8.3 Patients with Cancer

Patients undergoing cancer treatment face repeated needle procedures: blood draws, IV line placement, and subcutaneous or intramuscular injections. Needle phobia compounds the already immense burden of cancer treatment. Interventions should:

• Coordinate with oncology staff to minimize unnecessary needle sticks.

• Use numbing cream and distraction for all procedures.

• Provide psychological support before every needle exposure.

• Consider one‑session treatment during a chemotherapy cycle.

8.4 Patients with Co‑occurring Autism Spectrum Disorder (ASD)

Needle phobia is common among individuals with ASD, due to heightened sensory sensitivity (pain, sensation of needle insertion), difficulty with unpredictability, and prior aversive experiences. Interventions should:

• Use social stories to explain the procedure.

• Incorporate sensory accommodations (noise‑canceling headphones, weighted blankets).

• Allow extended time for preparation.

• Coordinate with medical staff to minimize waiting time and sensory overload.

Part 9: Collaboration with Medical Providers — Breaking the Avoidance Cycle

Psychotherapists cannot treat needle phobia in isolation. Successful treatment requires collaboration with the medical providers who perform the feared procedures.

Key collaborative strategies:

1. Establish a referral pathway: Identify physicians, nurses, or phlebotomists willing to work with anxious patients. Not all medical staff have the patience or training for this population.

2. Pre‑procedure planning: For a patient completing exposure therapy, coordinate a specific date and time for the actual blood draw or injection. The medical provider should know that the patient is undergoing exposure and that fainting is possible but not dangerous.

3. Graduated exposure in the medical setting: The patient may start by simply sitting in the examination room, then watching a video of a blood draw, then a dry needle, then the actual procedure. Each step may require multiple visits.

4. Use of topical anesthetics: Prescribe topical lidocaine cream (e.g., EMLA) to be applied 30‑60 minutes before the procedure. This reduces pain, which is an unconditioned stimulus maintaining the fear.

5. Positioning: Patients with vasovagal response should be lying down during the procedure, not sitting upright. This reduces the risk of fainting and injury.

6. Distraction and grounding: Medical staff can be trained to use simple distraction techniques (asking about the patient's weekend, playing music, having the patient count backward).

7. Post‑procedure debriefing: After the successful procedure (even if difficult), the patient and therapist should debrief. What worked? What was the worst part? How can the next procedure be even easier?

The goal: A patient who can tolerate necessary medical care without avoidance — even if the experience remains unpleasant. Complete elimination of fear is not necessary for functional improvement.

Part 10: Prognosis and Long‑Term Management

Needle phobia is highly treatable. The prognosis for patients who complete evidence‑based treatment is excellent.

10.1 Treatment Outcomes

• Exposure therapy (CBT): Approximately 70‑90 percent of patients with specific phobia show clinically significant improvement following 4‑8 sessions of CBT with exposure.

• Applied tension technique (ATT): Among patients with vasovagal response, ATT reduces fainting rates from 80 percent to 30‑40 percent.

• One‑session treatment (OST): Gains are typically maintained at 6‑12 month follow‑up.

10.2 Relapse Prevention

Phobias can recur, particularly after a long period without exposure. Patients should be encouraged to:

• Continue practicing ATT before medical appointments.

• Seek out opportunities for low‑stakes exposure (accompanying a friend to a blood draw, watching videos of injections).

• Return for booster sessions if avoidance re‑emerges.

10.3 When to Refer

Refer to a psychiatrist in the following circumstances:

• Patient is already on multiple psychotropic medications without improvement.

• Needle phobia is secondary to another condition (e.g., PTSD, psychotic disorder) requiring medication.

• Patient requires acute anxiolysis for an urgent medical procedure (e.g., benzodiazepines or procedural sedation).

• Patient is at imminent risk of self‑harm or suicide (unusual in isolated phobia but possible with comorbid depression).

Conclusion: The Phobia That Literally Causes Disease

F40.231 is often treated as a minor condition — an inconvenience, a quirk, something patients should "just get over." This dismissal is both clinically incorrect and ethically troubling.

Needle phobia is not trivial. It is a genuine, disabling psychiatric condition that prevents millions of people from accessing essential medical care. The patient who avoids blood draws may have undiagnosed diabetes. The patient who refuses vaccinations remains vulnerable to preventable infectious diseases. The patient who cannot tolerate insulin injections will have chronically poor glycemic control, with all the associated complications.

The psychotherapist who understands needle phobia — and who can diagnose it, treat it, and collaborate with medical providers to overcome it — is not merely providing a service. They may be saving a life.

Treat the phobia. Document the code. And never dismiss needle fear as "just a fear."

FAQ

Is F40.231 the same as fear of blood (F40.230)?

No. F40.231 specifically refers to fear of injections and transfusions (needles). F40.230 refers to fear of blood (hemophobia). The two commonly co‑occur but are distinct. A patient with F40.231 may have no difficulty seeing blood provided no needle is involved; a patient with F40.230 may panic at the sight of blood even without a needle. Accurate diagnosis requires identifying the specific phobic stimulus.

Does my patient need to faint to have needle phobia?

No. Fainting (vasovagal syncope) occurs in a significant subset of patients with blood‑injection‑injury phobia, but not all. Patients without the vasovagal subtype experience the sympathetic surge typical of other phobias: racing heart, rapid breathing, sweating, and panic. They do not faint. The presence or absence of fainting influences treatment selection (applied tension technique is needed only for those who faint).

Can needle phobia be treated without exposure to real needles?

Imaginal exposure (visualizing needle procedures) and virtual reality exposure can be effective, particularly for patients who cannot tolerate in‑vivo exposure initially. However, eventually, the patient will need to face a real needle to achieve functional improvement — otherwise, the phobia may persist, and the patient will continue to avoid necessary medical care.

How should I document medical necessity for F40.231 treatment?

Document the specific avoidance behaviors and their health consequences. Examples: "Patient has declined influenza vaccination for 5 years," "Has not had routine blood work in 8 years despite physician recommendation," "Avoids dental care due to fear of local anesthetic injection." The functional impairment in the healthcare domain is the key justification for treatment.

What CPT codes should I use for treating needle phobia?

Standard psychotherapy CPT codes apply, as treatment is not procedure‑specific. For a 45‑minute session of CBT with exposure, use 90834. For a 60‑minute session (e.g., for one‑session treatment or prolonged exposure), use 90837. For the initial diagnostic evaluation (history, mental status exam, diagnosis formulation), use 90791 (no medical services) or 90792 (with medical services, meaning you are a psychiatrist or under physician supervision).

References

1. ICD-10 Data. (2025). 2026 ICD-10-CM Diagnosis Code F40.231: Fear of injections and transfusions.

2. ICD-10 Data. (2025). 2026 ICD-10-CM Diagnosis Code F40.230: Fear of blood.

3. ICD-10 Data. (2025). 2026 ICD-10-CM Diagnosis Code F40.232: Fear of other medical care.

4. ICD-10 Data. (2025). 2026 ICD-10-CM Diagnosis Code F40.233: Fear of injury.

5. National Institutes of Health (NIH). (2023). Needle Phobia: Diagnosis and Management. National Library of Medicine.

6. Centers for Disease Control and Prevention (CDC). (2024). Vaccination Coverage Among Adults.